ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $19.42 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.